SOST and Marchiafava-Bignami disease: Furthermore, studies suggest that elevated levels of sclerostin in CKD increase the progression of periodontitis by inhibiting bone remodelling [110,111,112] and therefore, elevated sclerostin levels secondary to CKD-MBD may potentiate periodontitis-related alveolar bone loss [112,113].